Scrip Regulatory Affairs
The New EU Data Protection Regulation: What will the Impact be on the Life Sciences Industry?
March 2012
The EU Data Protection Regulation proposed by the European Commission in January will - if adopted in its current form - require pharmaceutical and medical device companies to adopt a new approach to data processing and data protection.
This article was published in the March 2012 issue of Scrip Regulatory Affairs.
得意分野
Suggested News & Insights
U.S. SEC Regulation S-P: Compliance Deadline Approaching for Smaller EntitiesApril 30, 2026European Biotech Act I: Navigating the EDPB/EDPS Vision for the Future of Clinical TrialsApril 29, 2026Sidley Represents OppFi In Its Acquisition of BNCC and BNC National BankApril 29, 2026Sidley Represents Liberty Mutual in US$750 Million Senior Notes OfferingApril 23, 2026Sidley Represents ModMed in Its Acquisition of Bonsai HealthApril 22, 2026U.S. SEC Clears Path for Decentralized Crypto Asset Security Trading With Broker Registration Exception for User InterfacesApril 21, 2026
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory